CISPLATIN URINARY PHARMACOKINETICS AND NEPHROTOXICITY - A COMMON CIRCADIAN MECHANISM
- 1 January 1982
- journal article
- research article
- Vol. 66 (11) , 1933-1938
Abstract
Renal toxicity and urinary pharmacokinetics following a nonlethal dose (5 mg/kg) of [the antineoplastic drug] cisplatin were investigated in female F344 (Fischer) rats that were on a standardized light-dark schedule, with water freely available. Circadian timing of drug administration had a major effect on the BUN [blood urea N] increase (P < 0.01), the urine volume increase (P < 0.025) and the urinary concentration of cisplatin following drug administration (P < 0.01). Renal toxicity was postively correlated with the peak urinary concentration of cisplatin and with the area under the curve of urinary concentration over the 1st 20 h after drug administration (P < 0.01). Drug administration near the normal circadian maximum of urinary volume prior to treatment resulted in the least renal toxicity, lowest peak and smallest area of urinary concentration of cisplatin.This publication has 6 references indexed in Scilit:
- EFFECTS OF MANNITOL OR FUROSEMIDE DIURESIS ON THE NEPHROTOXICITY AND PHYSIOLOGICAL DISPOSITION OF CIS-DICHLORODIAMMINEPLATINUM-(II) IN RATS1979
- Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in manCancer, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977
- The renal pathology in clinical trials of Cis-platinum (II) diamminedichlorideCancer, 1977
- Improvement of Cis-dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal modelCancer, 1977